Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy
- PMID: 11131461
- DOI: 10.1016/s0168-8278(00)80131-2
Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy
Abstract
Background/aim: A new gross classification of hepatocellular carcinoma in which Eggel's nodular type is subclassified into type 1 (single nodular type), type 2 (single nodular type with extranodular growth), and type 3 (contiguous multinodular type) has been widely used in Japan. The aim of the study was to determine whether this classification is correlated with patient outcome.
Methods: Sixty-five resected hepatocellular carcinoma nodules (< or = 5 cm) were classified using this new classification.
Results: The 65 tumors were classified into 30 type 1 (46%), 20 type 2 (31%), and 15 type 3 (23%) hepatocellular carcinomas. The rate of microscopic vascular invasion significantly increased from type 1 to type 2, and to type 3 tumors (p=0.03). Kaplan-Meier estimates showed that type 1 was significantly associated with lower recurrence rate (type 1 vs. type 2, p=0.01; type 1 vs. type 3, p=0.004; log-rank test), and higher disease-specific survival (type 1 vs. type 2, p=0.02; type 1 vs. type 3, p=0.002). Cox's proportional-hazards model demonstrated that type 1 was an independent factor for low risk of recurrence (p=0.002) and low risk of disease-specific death (p=0.02).
Conclusion: The gross classification of hepatocellular carcinoma is of clinical value in predicting patient outcome.
Comment in
-
Hepatocellular carcinoma and the art of prognostication.J Hepatol. 2000 Dec;33(6):1006-8. doi: 10.1016/s0168-8278(00)80137-3. J Hepatol. 2000. PMID: 11131437 Review. No abstract available.
Similar articles
-
The clinicopathological impact of gross classification on solitary small hepatocellular carcinoma.Hepatogastroenterology. 2013 Oct;60(127):1726-30. Hepatogastroenterology. 2013. PMID: 24627922
-
Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.World J Surg Oncol. 2017 Aug 22;15(1):156. doi: 10.1186/s12957-017-1229-x. World J Surg Oncol. 2017. PMID: 28830473 Free PMC article.
-
Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.World J Gastroenterol. 2015 Apr 28;21(16):4933-45. doi: 10.3748/wjg.v21.i16.4933. World J Gastroenterol. 2015. PMID: 25945007 Free PMC article.
-
Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.World J Gastroenterol. 2015 May 14;21(18):5598-606. doi: 10.3748/wjg.v21.i18.5598. World J Gastroenterol. 2015. PMID: 25987785 Free PMC article.
-
The role of macroscopic classification in nodular-type hepatocellular carcinoma.Am J Surg. 2001 Aug;182(2):177-82. doi: 10.1016/s0002-9610(01)00682-1. Am J Surg. 2001. PMID: 11574092
Cited by
-
The Clinicopathologic and Prognostic Significance of Gross Classification on Solitary Hepatocellular Carcinoma After Hepatectomy.Medicine (Baltimore). 2015 Aug;94(32):e1331. doi: 10.1097/MD.0000000000001331. Medicine (Baltimore). 2015. PMID: 26266378 Free PMC article.
-
Predictive models and early postoperative recurrence evaluation for hepatocellular carcinoma based on gadoxetic acid-enhanced MR imaging.Insights Imaging. 2023 Jan 8;14(1):4. doi: 10.1186/s13244-022-01359-5. Insights Imaging. 2023. PMID: 36617581 Free PMC article.
-
Proposal of objective morphological classification system for hepatocellular carcinoma using preoperative multiphase computed tomography.J Gastroenterol. 2014 Oct;49(10):1430-7. doi: 10.1007/s00535-013-0908-9. Epub 2013 Nov 16. J Gastroenterol. 2014. PMID: 24240709
-
The risk factors of early recurrence after hepatectomy in hepatocellular carcinoma.Ann Surg Treat Res. 2014 Jun;86(6):283-8. doi: 10.4174/astr.2014.86.6.283. Epub 2014 May 23. Ann Surg Treat Res. 2014. PMID: 24949318 Free PMC article.
-
The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma.Sci Rep. 2021 Jan 28;11(1):2415. doi: 10.1038/s41598-021-82058-x. Sci Rep. 2021. PMID: 33510294 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical